Parallel Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $710K | Buy |
3,625
+242
| +7% | +$47K | 0.01% | 598 |
|
|
2025
Q4 | $587K | Buy |
3,383
+21
| +0.6% | +$3.82K | 0.01% | 630 |
|
|
2025
Q3 | $641K | Sell |
3,362
-22
| -0.7% | -$3.9K | 0.01% | 572 |
|
|
2025
Q2 | $608K | Buy |
3,384
+100
| +3% | +$17.4K | 0.01% | 563 |
|
|
2025
Q1 | $556K | Sell |
3,284
-226
| -6% | -$37.1K | 0.01% | 553 |
|
|
2024
Q4 | $530K | Buy |
3,510
+158
| +5% | +$24.6K | 0.01% | 568 |
|
|
2024
Q3 | $520K | Buy |
3,352
+148
| +5% | +$22.1K | 0.01% | 552 |
|
|
2024
Q2 | $439K | Sell |
3,204
-144
| -4% | -$19.7K | 0.01% | 578 |
|
|
2024
Q1 | $446K | Sell |
3,348
-547
| -14% | -$71K | 0.01% | 573 |
|
|
2023
Q4 | $537K | Sell |
3,895
-201
| -5% | -$26.4K | 0.02% | 469 |
|
|
2023
Q3 | $499K | Sell |
4,096
-166
| -4% | -$22.1K | 0.02% | 460 |
|
|
2023
Q2 | $599K | Sell |
4,262
-118
| -3% | -$16.3K | 0.02% | 420 |
|
|
2023
Q1 | $620K | Sell |
4,380
-45
| -1% | -$6.44K | 0.02% | 402 |
|
|
2022
Q4 | $692K | Buy |
4,425
+267
| +6% | +$38.4K | 0.03% | 331 |
|
|
2022
Q3 | $510K | Sell |
4,158
-52
| -1% | -$6.85K | 0.02% | 386 |
|
|
2022
Q2 | $560K | Sell |
4,210
-6
| -0.1% | -$818 | 0.03% | 364 |
|
|
2022
Q1 | $586K | Sell |
4,216
-546
| -11% | -$76.1K | 0.02% | 390 |
|
|
2021
Q4 | $824K | Sell |
4,762
-351
| -7% | -$53.4K | 0.03% | 318 |
|
|
2021
Q3 | $743K | Buy |
5,113
+772
| +18% | +$113K | 0.03% | 311 |
|
|
2021
Q2 | $573K | Buy |
4,341
+66
| +2% | +$8.64K | 0.02% | 357 |
|
|
2021
Q1 | $549K | Buy |
4,275
+84
| +2% | +$10.4K | 0.03% | 330 |
|
|
2020
Q4 | $499K | Sell |
4,191
-22
| -0.5% | -$2.68K | 0.03% | 330 |
|
|
2020
Q3 | $482K | Sell |
4,213
-315
| -7% | -$37.2K | 0.03% | 314 |
|
|
2020
Q2 | $516K | Buy |
4,528
+634
| +16% | +$67.2K | 0.03% | 285 |
|
|
2020
Q1 | $312K | Buy |
3,894
+2,873
| +281% | +$297K | 0.03% | 343 |
|
|
2019
Q4 | $109K | Sell |
1,021
-91
| -8% | -$9.49K | 0.01% | 734 |
|
|
2019
Q3 | $119K | Buy |
1,112
+6
| +0.5% | +$616 | 0.01% | 662 |
|
|
2019
Q2 | $113K | Sell |
1,106
-17
| -2% | -$1.63K | 0.01% | 634 |
|
|
2019
Q1 | $101K | Sell |
1,123
-26
| -2% | -$2.25K | 0.01% | 604 |
|
|
2018
Q4 | $95K | Buy |
1,149
+16
| +1% | +$1.5K | 0.01% | 550 |
|
|
2018
Q3 | $122K | Hold |
1,133
| – | – | 0.02% | 545 |
|
|
2018
Q2 | $124K | Buy |
1,133
+2
| +0.2% | +$208 | 0.02% | 481 |
|
|
2018
Q1 | $113K | Sell |
1,131
-84
| -7% | -$8.6K | 0.02% | 466 |
|
|
2017
Q4 | $120K | Buy |
1,215
+38
| +3% | +$3.6K | 0.02% | 433 |
|
|
2017
Q3 | $108K | Sell |
1,177
-114
| -9% | -$12.1K | 0.02% | 456 |
|
|
2017
Q2 | $140K | Buy |
1,291
+12
| +0.9% | +$1.27K | 0.03% | 387 |
|
|
2017
Q1 | $137K | Buy |
1,279
+177
| +16% | +$16.9K | 0.03% | 369 |
|
|
2016
Q4 | $101K | Buy |
+1,102
| New | +$95K | 0.02% | 381 |
|
Other funds holding DGX
VCM
VPM
EIG
Parallel Advisors's DGX Position: Q1 2026 in Review
Parallel Advisors increased its Quest Diagnostics (DGX) stake by 7.2% in Q1 2026, buying an estimated $47K and bringing the position to 3,625 shares worth $710K. The position accounts for 0.01% of the portfolio, ranked #598.
Parallel Advisors first reported a position in DGX in Q4 2016 and has held it in 38 quarters since. The position peaked at $824K in Q4 2021. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Parallel Advisors held 3,625 shares of Quest Diagnostics worth $710K as of Q1 2026.
- Parallel Advisors bought 242 Quest Diagnostics shares in Q1 2026, an estimated $47K.
- Quest Diagnostics made up 0.01% of Parallel Advisors's portfolio in Q1 2026, its #598 holding.
- Parallel Advisors first reported a position in Quest Diagnostics in Q4 2016 and has held it in 38 quarters since.
- Parallel Advisors's Quest Diagnostics position peaked at $824K in Q4 2021.
- 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.